MRGPRX2 and allergic disease: Molecular docking analyses suggested that osthole could not compete with MRGPRX2 agonists, but rather regulated MRGPRX2 activation through allosteric modification, mainly by attenuating Ca2+ mobilization in vitro and inhibiting inflammation in mouse models of pseudo-allergy.73